Skip to main content

What the FDA labels say about taking them together

Dasatinib and famotidine

Famotidine's FDA label of February 6, 2026 names dasatinib in its drug interactions (prescription label) section; the dasatinib labels PlainMeds reads (3) do not name famotidine. The famotidine label: “Concomitant administration of famotidine with dasatinib, delavirdine mesylate, cefditoren, and fosamprenavir is not recommended.”

Check it at the source: the dasatinib FDA label on DailyMed (effective November 12, 2025, Alembic Pharmaceuticals Limited); the famotidine FDA label on DailyMed (effective February 6, 2026, Kenvue Brands LLC).

What does the dasatinib label say about famotidine?

Dasatinib's label (effective November 12, 2025) and its 2 other brand-application labels do not name famotidine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (DASATINIB), Alembic Pharmaceuticals Limited, effective November 12, 2025 (SPL set 645fcf26-1b2f-40c5-881b-8effe02defbd), via openFDA; the full label on DailyMed

What does the famotidine label say about dasatinib?

Famotidine label, drug interactions (prescription label)

Concomitant administration of famotidine with dasatinib, delavirdine mesylate, cefditoren, and fosamprenavir is not recommended.

Source: FDA drug label (Pepcid AC Original Strength), Kenvue Brands LLC, effective February 6, 2026 (SPL set 54f4086f-e443-4e7e-8c7e-94e152e1c256), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Dasatinib generic labelers
145Famotidine generic labelers
DasatinibFamotidine
Labeled forLeukemia, lymphoma and myelomaAcid reflux and ulcers
Boxed warningNoNo
Pharmacy cost (NADAC)$26.46 per tablet 100 mg tablet$0.0289 per tablet 20 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?